Additionally, through two‐step MR analysis from a genetic perspective, three immune cells were determined to play significant regulatory roles in the causal effects of FLI3L, CCL4, and OSM on these three types of skin cancer, providing a solid theoretical basis for clinical decision‐making. This evidence concerns the gene CCL4 and skin neoplasm.